The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intraperitoneal and intrapleural administrations of triamcinolone acetonide for control of malignant ascites and pleural effusion.
K. Inoue
No relevant relationships to disclose
H. Tsubamoto
No relevant relationships to disclose
K. Ito
No relevant relationships to disclose
K. Hori
No relevant relationships to disclose
R. Kanazawa
No relevant relationships to disclose
Y. Ito
No relevant relationships to disclose
S. Yamamoto
No relevant relationships to disclose
K. Onishi
No relevant relationships to disclose
R. Ando
No relevant relationships to disclose
S. Komori
No relevant relationships to disclose